For instance, SMAD3 was indicated in the CRC of representative cell lines of DLBCL, colorectal cancer, pancreatic, hepatocellular carcinoma, breast, and gastric cancers (Table 2). This evidence concerns the gene SMAD3 and diffuse large B-cell lymphoma.